Lacosamide Medley

Lacosamide, the active ingredient in Lacosamide Medley, is a Anticonvulsant presented as an oral tablet for Oral use. It is used to treat partial-onset seizures in patients with epilepsy. GNH USA supplies Lacosamide Medley as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant that targets neuronal hyperexcitability in focal seizure disorders. - Partial-onset seizures: reduces seizure frequency and severity in patients with focal epilepsy. - Epilepsy (focal): provides adjunctive control of seizures when used with other antiepileptic drugs. - Refractory focal epilepsy: may be added to improve seizure management in patients not responding to first‑line therapy.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Nausea: mild to moderate stomach upset. - Headache: tension‑type or throbbing pain. - Fatigue: unusual tiredness or lack of energy. - Blurred vision: temporary visual disturbances. - Diplopia: double vision episodes.

Serious or Rare Side Effects: - Suicidal ideation: thoughts of self‑harm requiring immediate evaluation. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: abnormal heart rhythms, especially PR‑interval prolongation. - Respiratory depression: slowed breathing in vulnerable patients. - Anaphylaxis: acute allergic reaction with airway compromise. - Liver injury: elevated hepatic enzymes or hepatitis.

Before initiating Lacosamide therapy, consider the following safety measures. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Cardiac conduction: obtain baseline ECG and monitor for PR‑interval changes. - Pregnancy: risk unknown; discuss potential benefits and risks with a healthcare professional. - Driving and operating machinery: caution advised due to possible dizziness or visual changes. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels. - Strong CYP3A4 inducers (e.g., carbamazepine): may reduce lacosamide effectiveness. - Other sodium‑channel blockers (e.g., phenytoin): heightened risk of CNS depression.

Moderate Interactions (Monitor Closely): - Alcohol: may exacerbate dizziness and sedation. - Other antiepileptics (e.g., valproate): monitor for additive side effects. - Antihypertensives: possible additive hypotensive effect. - Oral contraceptives: may reduce hormonal efficacy. - Serotonergic agents: watch for serotonin syndrome signs.